GlobeNewswire by notified

Monument Progresses Flotation Commissioning at Selinsing


The first filtered gold concentrate produced on December 27th, 2022

VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) ("Monument" or the "Company") is pleased to update the progress at the Selinsing Sulphide Project. With the completion of the flotation plant construction at the Selinsing Gold Mine in Malaysia, the sulphide treatment plant has been placed into commissioning after the oxide plant production ceased in mid-November 2022. The first gold concentrate was filtered on December 27, 2022 and the ramp up period commenced in January 2023.

President and CEO Cathy Zhai commented, “During commissioning we have identified some bottlenecks and are working with Mincore to fix them. Up to date the flotation plant has delivered saleable concentrate of approximately 1,707 dry tonnes at 35.12 g/t Au with gold content of 1,928 troy ounces. In the meantime, with unexpected heavy rainfall in the dry season, we also are focused on acceleration of the mining rates to fulfill commercial production requirement.”

Figure 1. Flotation Plant

To view this piece of content from, please give your consent at the top of this page.

Figure 2. Plant Inspection

To view this piece of content from, please give your consent at the top of this page.

Flotation Commissioning Progress

The commissioning stages include: (1) preparation - to confirm the completeness of construction and deliver the commissioning plan for test work, (2) dry commissioning - to test if mechanical, electrical and electronic equipment and components in the circuit are installed correctly and completely according to designed protocols and their availability, (3) wet commissioning - to test circulation of water through the flotation circuit and the plant as a whole ensure the water and pumping system up running for the designed purpose;(4) ore commissioning - to start-up with first fill to verify flotation performance and tune it to meet the designed performance in connection with front end circuit, this includes but not limited to the control level, the flows in relation to each components in the circuit and to overall treatment process, the water balance and mass balance. During the commissioning process the bottlenecks will be identified and corrected.   

After the start-up ore commissioning, a ramp up period will tune the plant under increased mill feed and required conditions until commercial production is reached. The management and board would consider the commercial production is reached when the flotation plant is running for 30 days continuously with production at 85% to 90% designed capacity.   

Progress Highlights

  • Construction of the flotation plant completed except weighbridge and the concentrate storage shed.
  • Dry and wet commissioning completed on flotation cells, concentrate and water recovery thickeners, reagents mixing and storage, blowers, compressor and filter press plant.
  • Ore commissioning started on December 15th,2022 with assistance from various consulting engineers: Mincore (engineering design), Metso-Outotec (thickeners), BGRIMM (flotation cells), Powerwell (MCC), Enertech (PLC and SCADA control system), McLanahan (filter press) and ISI Control (instrumentation control).
  • Ongoing improvements to flotation circuit, correcting shortfalls identified during ore commissioning period.
  • Flotation plant currently operating at 90% capacity and expected ramp-up to design capacity of 119 tph in March 2023.
  • As of February 22nd, 2023, a total of 1,707 dry metric tonnes of gold concentrate have been produced with an average gold grade of 35.12 g/t Au (1,928 troy ounces).

Figure 3: Operating Scada System

To view this piece of content from, please give your consent at the top of this page.

Figure 4: Concentrate Filter Cake Stockpile

To view this piece of content from, please give your consent at the top of this page.

Commissioning Technical Findings and Ramp up

As of February 22, 2023, a total of 1,707 tonnes of flotation concentrate have been produced at an average grade of 35.12 g/t Au. The flotation plant is currently operating at a mill feed rate of around 120 wet tonnes / 107 dry tonnes per hour or around 90% of design capacity. The mill feed rate will be increased over the next month with the aim of achieving and maintaining the design capacity of 119 tph by the end of March 2023.        

Some bottlenecks were identified during ore commissioning period that took longer time than expected, mainly caused by design deficiencies. While temporary solutions are in place to tune the plant to reach designed protocols and production level, actions have been undertaken to receive and review redesign from Mincore.

Both the flotation concentrate and the water recovery (flotation tailings) thickeners were successfully commissioned. The performance was compromised however by design deficiencies in relation to flotation tailings management; a stilling well was installed that stabilized the tailings pump operation as a temporary solution; the revised design for a tailings hopper sent by Mincore is currently under review.

The flotation concentrate pipeline and launder were found to be undersized; a new pipeline will be installed and new launder fabricated once the design is received. The concentrate thickener underflow pump has at times struggled to deliver concentrate to the filter press surge tank and modifications to both the pump suction and delivery lines are planned. The concentrate thickener overflow delivery line was undersized; an additional bigger diameter pipeline was installed as an interim solution; bigger pumps and pipelines will be installed.

The concentrate filter press has been successfully commissioned and initial filter cake containing around 20% moisture has been produced. Filter press commissioning was assisted by the manufacturer McLanahan who had direct on-line access to the control screen. Minor adjustments have been made to the automatic control system in an effort to lower the moisture level, this has been helped to some extent by coarsening the grind size and reducing the slimes content of the flotation concentrate.

In addition to the flotation plant construction, most ancillary buildings have been completed apart from the final concentrate shed, due to start in March 2023. Mechanical installation has been completed except for the weighbridge, which is ongoing, and the bagging system that has yet to be delivered. Power and instrumentation cabling have all been installed apart from that for the concentrate shed, the weighbridge and the bagging system.

About Monument

Monument Mining Limited (TSX-V: MMY, FSE:D7Q1) is an established Canadian gold producer that 100% owns and operates the Selinsing Gold Mine in Malaysia and the Murchison Gold Project in the Murchison area of Western Australia. It has 20% interest in Tuckanarra Gold Project jointly owned with Odyssey Gold Ltd in the same region. The Company employs approximately 200 people in both regions and is committed to the highest standards of environmental management, social responsibility, and health and safety for its employees and neighboring communities.

Cathy Zhai, President and CEO
Monument Mining Limited
Suite 1580 -1100 Melville Street
Vancouver, BC V6E 4A6

FOR FURTHER INFORMATION visit the company web site at or contact:

Richard Cushing, MMY Vancouver T: +1-604-638-1661 x102

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

Forward-Looking Statement

This news release includes statements containing forward-looking information about Monument, its business and future plans ("forward-looking statements"). Forward-looking statements are statements that involve expectations, plans, objectives or future events that are not historical facts and include the Company's plans with respect to its mineral projects and the timing and results of proposed programs and events referred to in this news release. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". The forward-looking statements in this news release are subject to various risks, uncertainties and other factors that could cause actual results or achievements to differ materially from those expressed or implied by the forward-looking statements. These risks and certain other factors include, without limitation: risks related to general business, economic, competitive, geopolitical and social uncertainties; uncertainties regarding the results of current exploration activities; uncertainties in the progress and timing of development activities; foreign operations risks; other risks inherent in the mining industry and other risks described in the management discussion and analysis of the Company and the technical reports on the Company's projects, all of which are available under the profile of the Company on SEDAR at Material factors and assumptions used to develop forward-looking statements in this news release include: expectations regarding the estimated cash cost per ounce of gold production and the estimated cash flows which may be generated from the operations, general economic factors and other factors that may be beyond the control of Monument; assumptions and expectations regarding the results of exploration on the Company's projects; assumptions regarding the future price of gold of other minerals; the timing and amount of estimated future production; the expected timing and results of development and exploration activities; costs of future activities; capital and operating expenditures; success of exploration activities; mining or processing issues; exchange rates; and all of the factors and assumptions described in the management discussion and analysis of the Company and the technical reports on the Company's projects, all of which are available under the profile of the Company on SEDAR at Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake to update any forward-looking statements, except in accordance with applicable securities laws.

Photos accompanying this announcement are available at

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Novo Nordisk A/S - share repurchase programme27.3.2023 16:07:25 CEST | Press release

Bagsværd, Denmark, 27March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 28 billion to be executed during a 12-month period beginning 1 February 2023. Under the programme initiated 1 February 2023, Novo Nordisk will repurchase B shares for an amount up to DKK 5.6 billion in the period from 1 February 2023 to 2 May 2023. Since the announcement 20 March, the following transactions have been made: Number of B sharesAverage purchase priceTransaction value, DKKAccumulated, last announcement3,025,1712,975,219,09720 March 202391,500987.8090,384,03221 March 202391,0001,000.2991,026,00422 March 202391,0001,017.9092,628,63523 March 202390,0001,025.7592,317,25224 March 202390

Acronis Earns 5-Star Rating in 2023 CRN® Partner Program Guide27.3.2023 16:00:00 CEST | Press release

This exclusive recognition is awarded to successful and committed channel-focused vendors in the IT space BURLINGTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Acronis, a global leader in cyber protection, today announced that CRN®, a brand of The Channel Company, has named the Acronis #CyberFit Partner Program with a prestigious 5-star rating in its 2023 Partner Program Guide. This annual guide offers essential information to solution providers such as managed service providers (MSPs), value-added resellers (VARs), systems integrators, and strategic service providers as they explore technology manufacturers’ partner programs to find the vendors that will best support their business needs. The 5-star rating is awarded to the companies that go above and beyond in their commitment to nurturing strong, profitable, successful channel partnerships. “We strive to make the Acronis #CyberFit Partner Program an easy, transparent, and powerful business development tool for our partners,” said Al

Kvika banki hf.: Annual General Meeting 30 March 2023 - Candidacy to the Board and amended proposals of the BoD27.3.2023 15:48:10 CEST | Press release

The deadline for candidacy to the Board expired on 25 March 2022. The following candidates have submitted their application for the Board of Directors at the AGM, to be held on 30 March, at 4:00 pm at Grand Hotel, Háteigur, Sigtún 28, 150 Reykjavík, also accessible online through Lumi AGM: In candidacy for the Board of Directors: Sigurður HannessonGuðmundur ÞórðarsonGuðjón ReynissonHelga Kristín AuðunsdóttirIngunn Svala Leifsdóttir In candidacy as alternate members: Helga Jóhanna OddsdóttirSigurgeir Guðlaugsson It is the assessment of the Board that all candidacies are valid in accordance with Act No. 2/1995 respecting Public Limited Companies. According to the company’s articles of association the Board of Directors shall consist of five members and two alternate members. As no further candidates have applied for the Board of Directors or as alternate members, the candidates are self-elected. Attention is drawn to an amendment proposal from Gildi Pension Fund regarding the wording of

07/2023 Green Hydrogen Systems - Financial calendar 2023 (updated)27.3.2023 15:45:00 CEST | Press release

Company announcement 07/2023 Green Hydrogen Systems updatesfinancial calendar for 2023 Kolding, Denmark, 27 March 2023 – Green Hydrogen Systems A/S hereby updates its financial calendar for 2023: Q1 2023 Trading Statement: 17 April 2023 (updated) Annual General Meeting: 18 April 2023 Q2 2023 Interim Report: 22 August 2023 Q3 2023 Trading Statement: 1 November 2023 For more info please contact: Investors: Jens Holm Binger, Head of Investor Relations, +45 6065 6525, Media: Jesper Buhl, Head of Public Affairs and Media Relations, +45 5351 5295, Green Hydrogen Systems in brief Green Hydrogen Systems is a clean technology company and a leading provider of standardised and modular electrolysers for the production of green hydrogen solely based on renewable energy. With its wide range of possible applications, green hydrogen plays a key role in the ongoing fundamental shift in our energy systems towards a net-zero emission society in 2050. As a result

NATALEE (TRIO033) Phase III trial demonstrates ribociclib significantly reduces the risk of recurrence for patients with early breast cancer, at interim analysis27.3.2023 15:28:42 CEST | Press release

EDMONTON, Alberta, March 27, 2023 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced positive topline results from NATALEE (TRIO033), a Novartis sponsored Phase III trial of ribociclib plus endocrine therapy (ET) as adjuvant treatment for patients with stages II and III early breast cancer (EBC) at risk of disease recurrence. NATALEE (TRIO033) met its primary endpoint at a pre-planned interim analysis, achieving a statistically significant improvement in invasive disease-free survival (iDFS) in women and men with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) EBC, when compared to ET alone. “At TRIO, we always strive to improve the lives of cancer patients by conducting clinical trials that might make a fundamental difference in outcomes. We are very proud of our collaboration with Novartis in the conduct of the NATALEE (TRIO033) trial. The results announced today are a significant step forward towards reducing the ris